Building access to the Regenstrief Institute is currently restricted. More on our coronavirus precautions.
See our coronavirus precautions.

Regenstrief Research Scientist Jennifer K. Maratt, M.D., M.S., co-authored a commentary in Gastroenterology about the benefits of gene-specific surveillance colonoscopy strategies for Lynch Syndrome, an inherited syndrome that increases the risk for colon cancer.

The editorial was published in conjunction with a paper from Columbia University. In that study, researchers created different surveillance strategies for each of the pathogenic variants linked to Lynch Syndrome. The strategies included varying starting ages for colonoscopies and surveillance intervals. They calculated each strategy’s cost-effectiveness in terms of colon cancer prevention and quality-adjusted life years. The best strategies varied based on the gene involved.

Dr. Maratt and co-author Joel Rubenstein, M.D., MSc, from the LTC Charles S. Kettles VA Medical Center and University of Michigan and concluded that based on this study, more colonoscopies might not always be the best approach. For some gene variants, less aggressive screening schedules might provide more value to patients by saving time and costs, while also yielding similar prevention rates. They state future studies are needed to understand if these strategies are feasible and acceptable to patients.

Dr. Maratt’s research focuses on colorectal cancer screening and surveillance and patient-centered approaches to reducing low-value care and optimizing appropriate care.

Tailoring Colorectal Cancer Surveillance in Lynch Syndrome: More Is Not Always Better” is published in Gastroenterology.

About Jennifer K. Maratt, M.D., M.S.

In addition to her role as a research scientist at Regenstrief, Jennifer K. Maratt, M.D., M.S., is an assistant professor for the Division of Gastroenterology and Hepatology at Indiana University School of Medicine. She is also a practicing gastroenterologist at IU Health and the Richard L. Roudebush Veterans Affairs Medical Center.

Related Influence

Nov 04, 2021 • Influence
Regenstrief data experts contribute to NEJM, CDC COVID-19 papers
Regenstrief Institute data experts are actively working to further the understanding of COVID-19 through real-world data. In the last week, the Regenstrief chief executive officer and a vice president have been lead authors on papers published in the U.S. Centers for Disease Control and Prevention (CDC)’s Morbidity and Mortality Weekly Report (MMWR). Regenstrief President and Chief Executive Officer Peter Embí, M.D., M.S., is first…
Continue Reading >
Oct 27, 2021 • Influence
Regenstrief research scientist co-authors national editorial to improve dementia care
Christopher M. Callahan, M.D., a Regenstrief Institute research scientist, co-authored an editorial in the Journal of the American Geriatrics Society (JAGS), “Improving care for dementia: Re-imagining the advocacy playbook,” that observes dementia care focused at the community, policy, and societal levels urgently requires more attention from researchers and clinicians. According to the Geriatrics Healthcare Professionals…
Continue Reading >